High‐dose methylprednisolone in nonintubated patients with severe COVID‐19 pneumonia
2020; Wiley; Volume: 51; Issue: 2 Linguagem: Inglês
10.1111/eci.13458
ISSN1365-2362
AutoresAikaterini Papamanoli, Jeanwoo Yoo, Prabhjot Grewal, William Predun, Jessica Hotelling, Robin Jacob, Azad Mojahedi, Hal A. Skopicki, Mohamed G. Mansour, Luis A. Marcos, Andreas P. Kalogeropoulos,
Tópico(s)Long-Term Effects of COVID-19
ResumoRecent trials with dexamethasone and hydrocortisone have demonstrated benefit in patients with coronavirus disease 2019 (COVID-19). Data on methylprednisolone are limited.
Referência(s)